Formulation and Evaluation of Extended-Release Solid Dispersion of Metformin Hydrochloride
2010
Extended-Release Solid Dispersion of Metformin Hydrochloride
publication
Evidence: moderate
Author Information
Author(s): Patil SA, Kuchekar BS, Chabukswar AR, Jagdale SC
Primary Institution: MAEER’s Maharashtra Institute of Pharmacy, Pune, India
Hypothesis
The study aims to formulate and characterize solid dispersion of metformin hydrochloride using methocel K100M as the carrier.
Conclusion
The solid dispersions of metformin with methocel K100M effectively prolonged the drug release for up to 10 hours.
Supporting Evidence
- The optimized formulation was subjected to accelerated stability testing as per ICH guidelines.
- Release data were examined kinetically to determine the best release profile.
- The study showed that solid dispersions can improve the bioavailability of poorly soluble drugs.
Takeaway
The researchers made a special version of a diabetes medicine that works longer so people don't have to take it as often.
Methodology
The study involved preparing solid dispersions of metformin using solvent evaporation and cogrinding methods, followed by various characterization techniques.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website